Literature DB >> 15489161

Molecular dynamics simulation links conformation of a pore-flanking region to hyperekplexia-related dysfunction of the inhibitory glycine receptor.

Hans-Georg Breitinger1, Harald Lanig, Christine Vohwinkel, Christof Grewer, Ulrike Breitinger, Tim Clark, Cord-Michael Becker.   

Abstract

Inhibitory glycine receptors mediate rapid synaptic inhibition in mammalian spinal cord and brainstem. The previously identified hyperekplexia mutation GLRA1(P250T), located within the intracellular TM1-2 loop of the GlyR alpha1 subunit, results in altered receptor activation and desensitization. Here, elementary steps of ion channel function of alpha1(250) mutants were resolved and shown to correlate with hydropathy and molar volume of residue alpha1(250). Single-channel recordings and rapid activation kinetic studies using laser pulse photolysis showed reduced conductance but similar open probability of alpha1(P250T) mutant channels. Molecular dynamics simulation of a helix-turn-helix motif representing the intracellular TM1-2 domain revealed alterations in backbone conformation, indicating an increased flexibility in these mutants that paralleled changes in elementary steps of channel function. Thus, the architecture of the TM1-2 loop is a critical determinant of ion channel conductance and receptor desensitization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15489161     DOI: 10.1016/j.chembiol.2004.07.008

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  10 in total

1.  Activation and desensitization induce distinct conformational changes at the extracellular-transmembrane domain interface of the glycine receptor.

Authors:  Qian Wang; Joseph W Lynch
Journal:  J Biol Chem       Date:  2011-09-14       Impact factor: 5.157

Review 2.  An outline of desensitization in pentameric ligand-gated ion channel receptors.

Authors:  Angelo Keramidas; Joseph W Lynch
Journal:  Cell Mol Life Sci       Date:  2012-08-31       Impact factor: 9.261

3.  Characterization of two mutations, M287L and Q266I, in the α1 glycine receptor subunit that modify sensitivity to alcohols.

Authors:  Cecilia M Borghese; Yuri A Blednov; Yu Quan; Sangeetha V Iyer; Wei Xiong; S John Mihic; Li Zhang; David M Lovinger; James R Trudell; Gregg E Homanics; R Adron Harris
Journal:  J Pharmacol Exp Ther       Date:  2011-10-28       Impact factor: 4.030

Review 4.  The dual-gate model for pentameric ligand-gated ion channels activation and desensitization.

Authors:  Marc Gielen; Pierre-Jean Corringer
Journal:  J Physiol       Date:  2018-04-17       Impact factor: 5.182

5.  The desensitization gate of inhibitory Cys-loop receptors.

Authors:  Marc Gielen; Philip Thomas; Trevor G Smart
Journal:  Nat Commun       Date:  2015-04-20       Impact factor: 14.919

6.  Inhibitory glycinergic neurotransmission in the mammalian auditory brainstem upon prolonged stimulation: short-term plasticity and synaptic reliability.

Authors:  Florian Kramer; Désirée Griesemer; Dennis Bakker; Sina Brill; Jürgen Franke; Erik Frotscher; Eckhard Friauf
Journal:  Front Neural Circuits       Date:  2014-03-10       Impact factor: 3.492

Review 7.  The impact of human hyperekplexia mutations on glycine receptor structure and function.

Authors:  Anna Bode; Joseph W Lynch
Journal:  Mol Brain       Date:  2014-01-09       Impact factor: 4.041

8.  Voltage-Dependent Inhibition of Glycine Receptor Channels by Niflumic Acid.

Authors:  Galyna Maleeva; Franck Peiretti; Boris S Zhorov; Piotr Bregestovski
Journal:  Front Mol Neurosci       Date:  2017-05-16       Impact factor: 5.639

9.  Mechanism of gating and partial agonist action in the glycine receptor.

Authors:  Jie Yu; Hongtao Zhu; Remigijus Lape; Timo Greiner; Juan Du; Wei Lü; Lucia Sivilotti; Eric Gouaux
Journal:  Cell       Date:  2021-02-09       Impact factor: 41.582

10.  A Change in the Ion Selectivity of Ligand-Gated Ion Channels Provides a Mechanism to Switch Behavior.

Authors:  Jennifer K Pirri; Diego Rayes; Mark J Alkema
Journal:  PLoS Biol       Date:  2015-09-08       Impact factor: 8.029

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.